AKT3 Gene Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome Type 2 Genetic Test sale cost 4400 AED
GDF6 Gene Klippel-Feil Syndrome Type 1 Autosomal Dominant Genetic Test sale cost 4400 AED GDF6 Gene Klippel-Feil Syndrome Type 1 Autosomal Dominant Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CDT1 Gene Meier-Gorlin Syndrome Type 4 Genetic Test sale cost 4400 AED CDT1 Gene Meier-Gorlin Syndrome Type 4 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

AKT3 Gene Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome Type 2 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The AKT3 Gene Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome Type 2 Genetic Test is a specialized diagnostic examination conducted to identify mutations in the AKT3 gene, which are associated with the development of the syndrome. This condition is characterized by abnormal brain development, leading to an enlarged brain (megalencephaly), excessive folds in the brain’s surface (polymicrogyria), the presence of extra fingers or toes (polydactyly), and the accumulation of excess cerebrospinal fluid in the brain (hydrocephalus).

DNA Labs UAE offers this comprehensive genetic test at a cost of 4400 AED. The test involves analyzing the patient’s DNA to detect mutations in the AKT3 gene, which plays a crucial role in brain development and function. By identifying these mutations, healthcare providers can confirm the diagnosis of Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome Type 2, enabling them to tailor treatment and management strategies to the specific needs of the patient. This genetic testing is a vital tool for families seeking answers to complex neurological conditions, offering insights that can guide medical care and support.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AKT3 Gene Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 Genetic Test

Test Name: AKT3 Gene Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 Genetic Test

Components: Blood Sample

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for AKT3 Gene Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AKT3 Gene Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 NGS Genetic DNA Test gene AKT3

Test Details: The AKT3 gene is associated with a rare genetic disorder called megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 (MPPH2). This syndrome is characterized by several features including an enlarged brain (megalencephaly), abnormal brain folds (polymicrogyria), extra fingers or toes (polydactyly), and accumulation of fluid in the brain (hydrocephalus). NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that can analyze multiple genes simultaneously to identify any mutations or variations that may be present. In the case of MPPH2, NGS testing can be used to analyze the AKT3 gene to identify any genetic changes that may be causing the syndrome. NGS genetic testing can help in confirming a diagnosis of MPPH2 and can also be used for carrier testing, prenatal testing, or for identifying other family members who may be at risk of inheriting the condition. It can provide valuable information for genetic counseling, management, and treatment options for individuals with MPPH2.

Test Name AKT3 Gene Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for AKT3 Gene Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AKT3 Gene Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 NGS Genetic DNA Test gene AKT3
Test Details

The AKT3 gene is associated with a rare genetic disorder called megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 (MPPH2). This syndrome is characterized by several features including an enlarged brain (megalencephaly), abnormal brain folds (polymicrogyria), extra fingers or toes (polydactyly), and accumulation of fluid in the brain (hydrocephalus).

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that can analyze multiple genes simultaneously to identify any mutations or variations that may be present. In the case of MPPH2, NGS testing can be used to analyze the AKT3 gene to identify any genetic changes that may be causing the syndrome.

NGS genetic testing can help in confirming a diagnosis of MPPH2 and can also be used for carrier testing, prenatal testing, or for identifying other family members who may be at risk of inheriting the condition. It can provide valuable information for genetic counseling, management, and treatment options for individuals with MPPH2.

SKU: TEST-4228 Category:

Related products